SOURCE: annual_report_text (1).txt
CHUNK: 801 of 1106
SIZE: 598 characters
PREVIOUS: chunk_0800_annual_report_text (1).txt
NEXT: chunk_0802_annual_report_text (1).txt
------------------------------
Inc, relates to the 
Dosimetry business and has been added to the 
CGU of Dosimetry given the cross synergies that 
will arise from this acquisition. The goodwill generated by an acquisition is 
allocated to the cash-generating units (CGUs) 
concerned and an impairment test is carried out 
annually on the CGUs fixed assets (including 
goodwill). The following table summarizes allocation of the 
carrying amount of goodwill by operating 
segment: December 31, 2022 
December 31, 2023 
(EUR 000) 
Proton therapy and Other 
accelerators 
Dosimetry 
Proton therapy and Other 
accelerators 
Dosimetry